Ethical guidelines for the 40th Annual Meeting of the Japan Society ofDrug Delivery System
Please submit your abstract for the 40th Annual Meeting of the Japan Society of Drug Delivery
System based on the following guidelines.
In accordance with the "Ethical Guidelines for Medical Research Involving Human Subjects," Youmust obtain institutional director approval based on an ethics review board, institutional review
board (IRB), equivalent advisory committee. In the case of observational research, institutional
director approval based on review by each advisory committee must be obtained. Only abstractsthat have been approved as above can be submitted.
In addition, for animal experiments and gene-related experiments, only abstracts that havebeen approved by each review committee or institutional review committee can be submitted.
If a presenter doesn’t comply with the above, that is, he or she is a member of the DDS
Society, the Board of Directors may consider revoking his or her qualification as a member ofthe DDS Society.

COI policy for the 40th Annual Meeting of the Japan Society of DrugDelivery System
COI policy
Conflict of interest (COI) is a situation that unfairly affects the responsibility ofresearchers and research institutions to ensure scientific objectivity and to protect theinterests of patients and subjects and poses significant risks. Specifically, there is concernthat the judgment of the results of medical research conducted through funding from commercialorganizations may affect the judgment of the results that should be fair if the judgment of theresults of medical research is advantageous or unfavorable to the funding source.
Target of disclosure and conditions
Disclosure of conflict of interest is required at the time of presentation.
All presenters are subject to disclosure.
The disclosure period is three years from the submission of the abstract.
If your presentation meets the following conditions, you will need to declare the status ofconflict of interest.
１．The title of the presentation is "Clinical research".
For the definition of "Clinical research", please refer to "Ethical guidelines for Clinicalresearch" (Ministry of Health,Labour and Welfare).
２．Within the past three years from the date of submission of your abstract, you must be paidby companies or for-profit organizations related to your presentation.
① As an officer or advisor of a company, corporate organization, or for-profit organization
In the case that the total annual income is more than 1 million JPY yen.
② Equity (shareholding, profit, etc.) of partner companies for industry-academia collaboration
activities
In the case that the annual profit from stocks (total of dividends and gains on sales) ismore than 1 million JPY yen, or if you own 5% or more of all the stocks concerned.
③ License and licensing fees from a company, organization or association
In the case that a patent license or one license fee is more than 1 million JPY yen per year

④ Daily allowance (lecture fee, etc.) paid by a company, organization or association for thetime and effort required of a researcher for attending (presenting) a conference.
In the case that the lecture fee from one company or organization is more than 500,000 JPY
yen⑤Manuscript fee paid by a company, organization or association for writing a pamphlet, etc.
In the case that the manuscript fee from one company or group is more than 500,000 yen peryear⑥Research funds provided by a company, organization, or association
In the case that the total amount of research contract expenses paid by a company or association
for medical research (contract research expenses, joint research expenses, clinical trials,etc.) in which the applicant can determine the actual use is more than 1 million JPY yen per
year⑦Scholarships (incentive) and donations provided by a company, organization or association
In cases where the total amount of donations that the applicant can decide how to use is morethan 1 million JPY yen per year from a company, organization or association to the applicant
or the department (department, field, etc.) or laboratory to which the applicant belongs.
⑧Donation course affiliation
In the case that the applicant belongs to a donation course provided by a company, organization
or association⑨Provision of reagents, equipment, services, etc.
In the case that reagents or equipment used in medical research are provided free of charge orat a particularly favorable price, or when data analysis and other services are provided⑩Special provision of travel, gifts, money and convenience that are not directly related toresearch
In the case that the total amount of donations received from a company, organization orassociation is more than 50,000 JPY yen per year※①"Officers or advisors of corporations, corporate organizations or for-profit organizations" means whena researcher belonging to a research institution assumes the position of director or advisor of a specificcompany and engages in regular and continuous activities under a contract to receive remuneration. At therequest of the other company, the provision of a single piece of advice, etc., should be declared as "thedaily allowance (lecture fee, etc.) paid by a company, organization or association for the time and effort
that the researcher is bound to attend the meeting (presentation)".
※It is necessary to declare in the case that for all the speakers, the department (lecture, field) or
research office is related to the publication of research results, which should be disclosed by the relevant
companies, organizations and associations in the COI relationship to provide research funds, scholarships
and donations related to research results in ⑥ or ⑦. In addition, the amount of money that the applicant
can decide to use effectively and the amount that the director of the research institute actually assigns
to the year is eligible from the total amount of research funds and donations provided by companies, etc.
※In the case that reagents and equipment used in medical research are provided free of charge

or at a particularly favorable price or data analysis or other services are provided, It is often
difficult to convert them into amount, so it is listed as "reagent", "equipment", "service" ,etc.in the ⑨.
How to disclose COI
Disclosure of COI is required at the time of giving a presentation. Information on COI should
be posted on the second part of the slide for an oral presentation and at the end of a poster
presentation.